-
Je něco špatně v tomto záznamu ?
Engineered Lactococcus lactis Secreting IL-23 Receptor-Targeted REX Protein Blockers for Modulation of IL-23/Th17-Mediated Inflammation
TV. Plavec, M. Kuchař, A. Benko, V. Lišková, J. Černý, A. Berlec, P. Malý,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
16-27676A
Czech Health Research Council, Ministry of Health of the Czech Republic
SAZU-16-01
Czech Academy of Sciences (CAS) and Slovenian Academy of Sciences and Arts (SAZU)
RVO: 86652036
Institutional Research Concept
BIOCEV CZ.1.05/1.1.00/02.0109
European Regional Development Fund
P4-0127 and J4-9327
Slovenian Research Agency (ARRS)
NV16-27676A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
Directory of Open Access Journals
od 2013
PubMed Central
od 2013
Europe PubMed Central
od 2013
ProQuest Central
od 2013-01-01
Open Access Digital Library
od 2013-01-01
Open Access Digital Library
od 2013-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2013
- Publikační typ
- časopisecké články MeSH
Lactococcus lactis, a probiotic bacterium of food origin, has recently been demonstrated as a suitable strain for the production and in vivo delivery of therapeutically important proteins into the gut. We aimed to engineer recombinant L. lactis cells producing/secreting REX binding proteins that have been described as IL-23 receptor (IL-23R) blockers and IL-23R antagonists suppressing the secretion of cytokine IL-17A, a pivotal step in the T-helper Th17-mediated pro-inflammatory cascade, as well as in the development of autoimmune diseases, including inflammatory bowel disease (IBD). To reach this goal, we introduced cDNA sequences coding for REX009, REX115, and REX125 proteins into plasmid vectors carrying a Usp45 secretion signal, a FLAG tag sequence consensus, and a LysM-containing cA surface anchor (AcmA), thus allowing cell-surface peptidoglycan anchoring. These plasmids, or their non-FLAG/non-AcmA versions, were introduced into L. lactis host cells, thus generating unique recombinant L. lactis-REX strains. We demonstrate that all three REX proteins are expressed in L. lactis cells and are efficiently displayed on the bacterial surface, as tested by flow cytometry using an anti-FLAG antibody conjugate. Upon 10-fold concentration of the conditioned media, a REX125 secretory variant can be detected by Western blotting. To confirm that the FLAG/non-FLAG REX proteins displayed by L. lactis retain their binding specificity, cell-surface interactions of REX proteins with an IL-23R-IgG chimera were demonstrated by flow cytometry. In addition, statistically significant binding of secreted REX009 and REX115 proteins to bacterially produced, soluble human IL-23R was confirmed by ELISA. We conclude that REX-secreting L. lactis strains were engineered that might serve as IL-23/IL-23R blockers in an experimentally induced mouse model of colitis.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028963
- 003
- CZ-PrNML
- 005
- 20210310102511.0
- 007
- ta
- 008
- 190813s2019 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/microorganisms7050152 $2 doi
- 035 __
- $a (PubMed)31137908
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Plavec, Tina Vida $u Department of Biotechnology, Jožef Stefan Institute, Jamova 39, SI-1000 Ljubljana, Slovenia. tina.plavec@ijs.si. Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, SI-1000 Ljubljana, Slovenia. tina.plavec@ijs.si.
- 245 10
- $a Engineered Lactococcus lactis Secreting IL-23 Receptor-Targeted REX Protein Blockers for Modulation of IL-23/Th17-Mediated Inflammation / $c TV. Plavec, M. Kuchař, A. Benko, V. Lišková, J. Černý, A. Berlec, P. Malý,
- 520 9_
- $a Lactococcus lactis, a probiotic bacterium of food origin, has recently been demonstrated as a suitable strain for the production and in vivo delivery of therapeutically important proteins into the gut. We aimed to engineer recombinant L. lactis cells producing/secreting REX binding proteins that have been described as IL-23 receptor (IL-23R) blockers and IL-23R antagonists suppressing the secretion of cytokine IL-17A, a pivotal step in the T-helper Th17-mediated pro-inflammatory cascade, as well as in the development of autoimmune diseases, including inflammatory bowel disease (IBD). To reach this goal, we introduced cDNA sequences coding for REX009, REX115, and REX125 proteins into plasmid vectors carrying a Usp45 secretion signal, a FLAG tag sequence consensus, and a LysM-containing cA surface anchor (AcmA), thus allowing cell-surface peptidoglycan anchoring. These plasmids, or their non-FLAG/non-AcmA versions, were introduced into L. lactis host cells, thus generating unique recombinant L. lactis-REX strains. We demonstrate that all three REX proteins are expressed in L. lactis cells and are efficiently displayed on the bacterial surface, as tested by flow cytometry using an anti-FLAG antibody conjugate. Upon 10-fold concentration of the conditioned media, a REX125 secretory variant can be detected by Western blotting. To confirm that the FLAG/non-FLAG REX proteins displayed by L. lactis retain their binding specificity, cell-surface interactions of REX proteins with an IL-23R-IgG chimera were demonstrated by flow cytometry. In addition, statistically significant binding of secreted REX009 and REX115 proteins to bacterially produced, soluble human IL-23R was confirmed by ELISA. We conclude that REX-secreting L. lactis strains were engineered that might serve as IL-23/IL-23R blockers in an experimentally induced mouse model of colitis.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kuchař, Milan $u Laboratory of Ligand Engineering, Institute of Biotechnology of the Czech Academy of Sciences, v. v. i., BIOCEV Research Center, Průmyslová 595, 252 50 Vestec, Czech Republic. milan.kuchar@ibt.cas.cz.
- 700 1_
- $a Benko, Anja $u Department of Biotechnology, Jožef Stefan Institute, Jamova 39, SI-1000 Ljubljana, Slovenia. benko.anja@gmail.com. Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, SI-1000 Ljubljana, Slovenia. benko.anja@gmail.com.
- 700 1_
- $a Lišková, Veronika $u Laboratory of Ligand Engineering, Institute of Biotechnology of the Czech Academy of Sciences, v. v. i., BIOCEV Research Center, Průmyslová 595, 252 50 Vestec, Czech Republic. veronika.liskova@ibt.cas.cz.
- 700 1_
- $a Černý, Jiří $u Laboratory of Structural Bioinformatics of Proteins, Institute of Biotechnology of the Czech Academy of Sciences, v. v. i., BIOCEV Research Center, Průmyslová 595, 252 50 Vestec, Czech Republic. jiri.cerny@ibt.cas.cz.
- 700 1_
- $a Berlec, Aleš $u Department of Biotechnology, Jožef Stefan Institute, Jamova 39, SI-1000 Ljubljana, Slovenia. ales.berlec@ijs.si. Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, SI-1000 Ljubljana, Slovenia. ales.berlec@ijs.si.
- 700 1_
- $a Malý, Petr $u Laboratory of Ligand Engineering, Institute of Biotechnology of the Czech Academy of Sciences, v. v. i., BIOCEV Research Center, Průmyslová 595, 252 50 Vestec, Czech Republic. petr.maly@ibt.cas.cz.
- 773 0_
- $w MED00198767 $t Microorganisms $x 2076-2607 $g Roč. 7, č. 5 (2019)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31137908 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20210310102507 $b ABA008
- 999 __
- $a ind $b bmc $g 1434112 $s 1067423
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 7 $c 5 $e 20190527 $i 2076-2607 $m Microorganisms $n Microorganisms $x MED00198767
- GRA __
- $a 16-27676A $p Czech Health Research Council, Ministry of Health of the Czech Republic
- GRA __
- $a SAZU-16-01 $p Czech Academy of Sciences (CAS) and Slovenian Academy of Sciences and Arts (SAZU)
- GRA __
- $a RVO: 86652036 $p Institutional Research Concept
- GRA __
- $a BIOCEV CZ.1.05/1.1.00/02.0109 $p European Regional Development Fund
- GRA __
- $a P4-0127 and J4-9327 $p Slovenian Research Agency (ARRS)
- GRA __
- $a NV16-27676A $p MZ0
- LZP __
- $a Pubmed-20190813